
Bavarian Nordic preps chikungunya vaccine filings
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph

Biotech investment in UK ticks up in Q2
Despite the economic downturn, UK life sciences companies raised a healthy £382 million ($486 million) in new financing in the second quarter of the year, with venture cap

UK opens '100-day' rapid-response vaccine unit
The UK government has formally opened a state-of-the-art vaccine research facility based at the UK Health and Security Agency (UKHSA) to improve the country's preparedness

Astellas' Iveric takeover rewarded with FDA nod for GA drug
The FDA has approved a new drug for sight-robbing disease geographic atrophy from Astellas, just a few weeks after the company

Zuranolone cleared for post-partum depression, but not MDD
Biogen and Sage Therapeutics' zuranolone has become the first oral drug to be approved by the FDA for post-partum depression (PPD), but the US regulator turned down a requ
Partner Content
8c10.jpg)
Mastering Engagement: How Do AI and ML Drive Pharma's Omnich...
Many articles on artificial intelligence (AI) promise amazing results, tons of money, and thousands of new clients, all thanks to the magical tool.

Rare Conditions and the Need for Support & Connection
Among various challenges, living with a rare condition can be quite lonely.

How to Use a Content Experience Platform in Pharma
Every marketer and sales representative shares a common desire: to achieve more with less effort.

The Critical Importance of Community KOLs
The top global KOLs in a therapy area might offer some insight into HCP behaviour in their geographies, but to understand the national and local challenges in a target region, you’ll need c

2nd Lipid Nanoparticle Development Europe Summit
Expedite LNP Applications for Next Generation Therapeutics beyond mRNA with Optimised Formulation, Scalability & Regulatory Compliance at Forefront of Mind